- Home
- IMNN vs ELWS Comparison
IMNN vs ELWS Comparison
Compare IMNN & ELWS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMNN
- ELWS
- Stock Information
- Founded
- IMNN 1982
- ELWS 2018
- Country
- IMNN United States
- ELWS Japan
- Employees
- IMNN N/A
- ELWS N/A
- Industry
- IMNN Biotechnology: Pharmaceutical Preparations
- ELWS
- Sector
- IMNN Health Care
- ELWS
- Exchange
- IMNN Nasdaq
- ELWS Nasdaq
- Market Cap
- IMNN 12.1M
- ELWS 12.1M
- IPO Year
- IMNN 1985
- ELWS 2023
- Fundamental
- Price
- IMNN $5.75
- ELWS $2.31
- Analyst Decision
- IMNN Buy
- ELWS
- Analyst Count
- IMNN 2
- ELWS 0
- Target Price
- IMNN $182.61
- ELWS N/A
- AVG Volume (30 Days)
- IMNN 55.7K
- ELWS 75.2K
- Earning Date
- IMNN 11-06-2025
- ELWS 09-30-2025
- Dividend Yield
- IMNN N/A
- ELWS N/A
- EPS Growth
- IMNN N/A
- ELWS N/A
- EPS
- IMNN N/A
- ELWS N/A
- Revenue
- IMNN N/A
- ELWS $3,083,071.00
- Revenue This Year
- IMNN N/A
- ELWS N/A
- Revenue Next Year
- IMNN N/A
- ELWS N/A
- P/E Ratio
- IMNN N/A
- ELWS N/A
- Revenue Growth
- IMNN N/A
- ELWS 145.52
- 52 Week Low
- IMNN $4.83
- ELWS $1.64
- 52 Week High
- IMNN $41.22
- ELWS $10.50
- Technical
- Relative Strength Index (RSI)
- IMNN 36.86
- ELWS 43.15
- Support Level
- IMNN $5.53
- ELWS $1.90
- Resistance Level
- IMNN $5.89
- ELWS $2.44
- Average True Range (ATR)
- IMNN 0.32
- ELWS 0.24
- MACD
- IMNN 0.07
- ELWS -0.01
- Stochastic Oscillator
- IMNN 23.81
- ELWS 32.46
About IMNN Imunon Inc.
Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across various human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. Its clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer that has completed Phase II clinical studies. Additionally, the Company has entered a first-in-human study of its COVID-19 booster vaccine (IMNN-101).
About ELWS Earlyworks Co. Ltd.
Earlyworks Co Ltd is a blockchain-based technology company. It builds products, delivers services, and develops solutions based on a proprietary grid ledger system to leverage blockchain technology in various business settings, including advertisement tracking, online visitor management, and sales of non-fungible tokens. The company's customers represent a diverse range of industries, such as information technology, shipping, real estate, entertainment, cosmetics, and chemical products.